Medicinova (MNOV) Assets Average (2011 - 2026)
Medicinova (MNOV) posted quarterly Assets Average of $46.6 million for Q4 2025, down 18.26% year-over-year from $57.0 million in Q4 2024, and down 4.33% quarter-over-quarter from $48.7 million in Q3 2025.
Medicinova (MNOV) Assets Average (2011 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Assets Average for 15 consecutive years, with $46.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets Average fell 18.26% year-over-year to $46.6 million; the TTM figure through Dec 2025 stood at $46.6 million (down 18.26% YoY), while the FY2025 annual figure was $50.7 million, down 16.92% from the prior year.
- Assets Average retreated to $46.6 million in Q4 2025 per MNOV's latest filing, from $48.7 million in the prior quarter.
- Across five years, Assets Average topped out at $94.9 million in Q2 2021 and bottomed at $46.6 million in Q4 2025.
- Historically, Assets Average has averaged $70.4 million across 5 years, with a median of $69.2 million in 2023.
- Annual changes were most pronounced in 2021 — Assets Average gained 24.16% — and 2025, when it dropped 18.26%.
- Medicinova's Assets Average stood at $89.5 million in 2021, then declined by 14.79% to $76.3 million in 2022, then fell by 11.89% to $67.2 million in 2023, then dropped by 15.19% to $57.0 million in 2024, then decreased by 18.26% to $46.6 million in 2025.
- Business Quant data shows MNOV's Assets Average at $46.6 million in Q4 2025, $48.7 million in Q3 2025, and $51.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Medicinova | 66.94 Mn | 66.94 Mn | 317,759.00 | 43.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.02 Mn |
| Dec 31, 2025 | 46.59 Mn |
| Sep 30, 2025 | 48.70 Mn |
| Jun 30, 2025 | 51.13 Mn |
| Mar 31, 2025 | 54.15 Mn |
| Dec 31, 2024 | 57.00 Mn |
| Sep 30, 2024 | 59.26 Mn |
| Jun 30, 2024 | 61.65 Mn |
| Mar 31, 2024 | 64.58 Mn |
| Dec 31, 2023 | 67.20 Mn |
| Sep 30, 2023 | 68.43 Mn |
| Jun 30, 2023 | 69.93 Mn |
| Mar 31, 2023 | 72.64 Mn |
| Dec 31, 2022 | 76.27 Mn |
| Sep 30, 2022 | 79.81 Mn |
| Jun 30, 2022 | 82.71 Mn |
| Mar 31, 2022 | 85.79 Mn |
| Dec 31, 2021 | 89.52 Mn |
| Sep 30, 2021 | 92.65 Mn |
| Jun 30, 2021 | 94.89 Mn |